Sanofi (NASDAQ:SNY) Upgraded to Strong-Buy at Hsbc Global Res

Sanofi (NASDAQ:SNY - Get Free Report) was upgraded by analysts at Hsbc Global Res to a "strong-buy" rating in a research note issued on Monday,Zacks.com reports.

A number of other brokerages also recently commented on SNY. The Goldman Sachs Group started coverage on shares of Sanofi in a research report on Friday, March 21st. They set a "neutral" rating and a $65.00 price objective for the company. Sanford C. Bernstein upgraded Sanofi to a "strong-buy" rating in a research report on Thursday, January 30th. BNP Paribas assumed coverage on Sanofi in a research note on Tuesday, April 15th. They issued an "outperform" rating and a $65.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a "sell" rating to a "hold" rating in a research report on Thursday, January 30th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Sanofi has a consensus rating of "Buy" and a consensus target price of $63.33.

Sanofi Stock Performance

NASDAQ SNY traded up $1.34 during trading on Monday, reaching $55.44. The company's stock had a trading volume of 2,254,692 shares, compared to its average volume of 2,349,452. The business's fifty day moving average price is $54.53 and its 200-day moving average price is $52.05. Sanofi has a twelve month low of $45.80 and a twelve month high of $60.12. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. The firm has a market cap of $140.06 billion, a price-to-earnings ratio of 22.27, a P/E/G ratio of 1.01 and a beta of 0.57.

Sanofi (NASDAQ:SNY - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $0.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.04. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. The firm had revenue of $10.41 billion for the quarter, compared to analysts' expectations of $9.79 billion. During the same quarter in the previous year, the firm posted $1.78 EPS. The firm's revenue for the quarter was down 11.0% on a year-over-year basis. As a group, analysts anticipate that Sanofi will post 4.36 EPS for the current fiscal year.

Institutional Trading of Sanofi

Several institutional investors and hedge funds have recently modified their holdings of SNY. Synergy Asset Management LLC purchased a new stake in Sanofi in the 4th quarter valued at approximately $25,000. McClarren Financial Advisors Inc. lifted its position in shares of Sanofi by 952.6% in the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company's stock valued at $28,000 after acquiring an additional 543 shares in the last quarter. Golden State Wealth Management LLC boosted its stake in shares of Sanofi by 619.3% during the first quarter. Golden State Wealth Management LLC now owns 633 shares of the company's stock valued at $35,000 after acquiring an additional 545 shares during the last quarter. Bessemer Group Inc. increased its position in Sanofi by 59.8% during the 4th quarter. Bessemer Group Inc. now owns 647 shares of the company's stock worth $32,000 after purchasing an additional 242 shares in the last quarter. Finally, Lee Danner & Bass Inc. acquired a new position in Sanofi in the 4th quarter valued at about $31,000. Hedge funds and other institutional investors own 14.04% of the company's stock.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.